Scientists and principals at KLEO Pharmaceuticals, on the third floor of 25 Science Park, were on hand recently to receive Sen. Chris Murphy’s Innovator of the Month award and to mark the opening of expanded lab space.
KLEO was founded on research by Yale chemist David Spiegel. It has progressed to the point where the first human studies of its synthetic immuno-therapy drug will likely be launched at the end of this year or in early 2020, said CEO Doug Manion. more